Aims & Scope

The aim of the journal is to critically (without ideological bias) evaluate the current achievements in every field of neuropsychiatry, particularly illness course and treatment effectiveness.

It is very important to know how a patient could be defined as improved or recovered, how long a treatment has to last, when therapy works and for whom.

These are fundamental issues for Clinical Neuropsychiatry.

The main goal of the journal is to collect original papers that directly or indirectly influence the effectiveness of a treatment, particularly focused on Evidence Based Medicine and Clinical Practice.

All papers in this journal are peer-reviewed.

No person is permitted to take any role in the review of a paper in which they have an interest, e.g., fees or grants from, employment by, consultancy for, shared ownership in, any close relationship with, an organisation whose interests, financial or otherwise, may be affected by the publication of the paper.

Giovanni Fioriti Editore’s policy is to publish clinical issue done by experts in their field.

All work published is rigorously checked – blind evaluation by at least one reviewer and two editors – whether it is an editorial, review, in-depth article, letter, or a case report.

View Aims & Scope

Metrics & Ranking

Impact Factor

Year Value
2025 2.4
2024 2.00

SJR (SCImago Journal Rank)

Year Value
2024 0.947

Quartile

Year Value
2024 Q2

h-index

Year Value
2024 38

Journal Rank

Year Value
2024 5293

Journal Citation Indicator

Year Value
2024 358

Impact Factor Trend


Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.


Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.


Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.


Quick Facts

Current Factor
2.4
First Published: 2025

SJR (SCImago Journal Rank)

SJR
0.947
First Published: 2024

Quartile

Current Quartile
Q2
First Published: 2024

Similar Journals

Top Journals in Related Fields